GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

Medy Tox 086900.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

63,900

-0.16%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩247.29bn

FY2016FY2025

Net income

₩16.59bn

FY2016FY2025

Free cash flow

₩27.19bn

FY2016FY2025

Shareholders' equity

₩451.84bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue₩247.29bn₩228.62bn₩221.12bn₩195.10bn₩184.87bn₩140.83bn₩205.90bn₩205.44bn₩181.24bn₩133.26bn
Research and development₩29.19bn₩29.82bn₩25.13bn₩23.32bn₩23.27bn₩32.54bn—₩19.08bn₩19.06bn₩8.27bn
Operating income₩17.01bn₩18.82bn₩24.26bn₩46.67bn₩130.35bn−₩38.42bn₩22.92bn₩83.92bn₩86.99bn₩75.17bn
Net income₩16.59bn₩16.95bn₩9.76bn₩37.01bn₩94.15bn−₩29.58bn₩26.21bn₩69.96bn₩70.11bn₩59.23bn
Diluted earnings per share2,546.082,546.011,449.685,840.0815,548.83-4,843.534,264.0212,855.3012,814.149,063.80

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets₩581.76bn₩615.16bn₩611.62bn₩596.29bn₩577.70bn₩467.76bn₩421.53bn₩395.01bn₩380.95bn₩324.03bn
Cash and short-term investments—₩59.51bn₩33.35bn₩26.21bn₩81.93bn₩55.61bn₩23.52bn₩25.38bn₩33.37bn₩29.34bn
Total liabilities₩127.47bn₩144.38bn₩137.14bn₩168.24bn₩178.22bn₩226.37bn₩162.38bn₩142.43bn₩189.29bn₩176.35bn
Debt₩18.00bn₩87.18bn₩82.83bn₩120.86bn₩132.92bn₩147.41bn₩102.44bn₩83.81bn₩114.23bn₩101.51bn
Shareholders' equity₩451.84bn₩466.48bn₩469.46bn₩428.04bn₩399.48bn₩241.40bn₩259.15bn₩252.59bn₩191.65bn₩147.68bn
Shares outstanding7m7m7m6m6m6m6m5m5m7m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations₩61.41bn₩36.89bn₩13.52bn₩26.20bn₩19.97bn₩27.93bn₩33.70bn₩55.07bn₩56.55bn₩54.10bn
Capital spending−₩34.22bn−₩18.72bn−₩37.47bn−₩9.90bn−₩17.51bn−₩41.14bn−₩21.02bn−₩8.50bn−₩38.04bn−₩144.67bn
Free cash flow₩27.19bn₩18.17bn−₩23.95bn₩16.30bn₩2.45bn−₩13.22bn₩12.68bn₩46.57bn₩18.50bn−₩90.57bn
Dividends paid−₩8.92bn−₩8.42bn−₩8.42bn−₩8.04bn−₩8.04bn−₩5.54bn−₩4.33bn−₩12.14bn−₩11.12bn−₩9.60bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩68.70bn₩60.69bn₩60.67bn₩61.02bn₩61.65bn₩63.96bn₩55.18bn₩53.85bn
Operating income₩4.76bn₩7.37bn−₩3.69bn₩8.90bn₩6.32bn₩5.48bn₩946.7m₩6.00bn
Net income₩3.11bn₩7.80bn−₩3.02bn₩7.43bn₩8.37bn₩3.81bn₩3.20bn₩3.81bn
Diluted earnings per share476.671,196.22-463.071,130.001,272.72578.43481.22565.99
Cash from operations₩9.21bn₩24.35bn₩15.79bn₩19.03bn₩9.75bn₩16.86bn₩15.67bn₩12.14bn
Capital spending−₩5.91bn−₩4.36bn−₩13.58bn−₩6.46bn−₩7.91bn−₩6.27bn−₩4.83bn−₩13.89bn
Free cash flow₩3.30bn₩19.99bn₩2.21bn₩12.57bn₩1.84bn₩10.59bn₩10.84bn−₩1.75bn
Total assets₩571.87bn₩564.78bn₩581.76bn₩586.91bn₩581.39bn₩603.18bn₩615.16bn₩625.49bn
Cash and short-term investments——————₩59.51bn₩27.70bn
Debt₩37.00bn₩37.50bn₩18.00bn₩18.50bn₩19.00bn₩19.50bn₩80.59bn₩62.33bn
Shareholders' equity₩374.45bn₩374.89bn₩451.84bn₩465.04bn₩462.09bn₩461.61bn₩466.48bn₩493.42bn

Financial ratios

Data as of 30 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020FY2018FY2017
Operating margin6.9%8.2%11.0%23.9%70.5%-27.3%——
Net margin6.7%7.4%4.4%19.0%50.9%-21.0%——
Return on equity3.7%3.6%2.1%8.6%23.6%-12.3%——
Return on assets2.9%2.8%1.6%6.2%16.3%-6.3%——
Free cash flow yield——————16.4%24.3%
Revenue growth8.2%3.4%13.3%5.5%31.3%-31.6%——
Earnings growth-2.1%73.8%-73.6%-60.7%-418.3%-212.9%——
Current ratio1.48x1.59x1.31x1.00x1.49x1.18x——
Debt to equity0.04x0.17x0.13x0.19x0.30x0.61x——
Equity ratio77.7%75.8%76.8%71.8%69.2%51.6%——
Interest coverage26.19x10.90x10.40x20.17x27.27x-9.20x——
R&D as a share of sales11.8%13.0%11.4%12.0%12.6%23.1%——
Buybacks as a share of market value——————0.5%—

Growth per year

Compound annual rate

3 years5 years10 years
Revenue8.2%11.9%10.8%
Operating income-28.6%—-10.4%
Net income-23.5%—-8.9%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin7.5%12.0%16.3%25.5%
Net margin7.0%9.0%11.9%20.3%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings47.549.0166.221.98.8-32.861.037.730.832.0
Price to sales3.23.67.34.24.56.97.812.811.914.2

Dividends and splits

Per share, in the currency the company pays

Paid for 4 years. Last went ex-dividend on 29 Sept 2025.

FY2025FY2024FY2023FY2022FY2020FY2019FY2018FY2017
Paid in the year1,200.001,100.001,100.00952.381863.838670.942732.8251,791.35
  • 21-for-20 split · 28 Dec 2022
  • 21-for-20 split · 29 Dec 2021
  • 21-for-20 split · 29 Dec 2020
  • 1.03-for-1 split · 27 Dec 2019
  • 1.03-for-1 split · 27 Dec 2018
  • 1.03-for-1 split · 29 Dec 2009

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.